Factors influencing individual results include: Baseline metabolic health and insulin resistance Adherence to dietary and physical activity recommendations Genetic predisposition to weight loss Concurrent medications that may affect weight Psychological factors and eating behaviours Patients should maintain realistic expectations: whilst significant abdominal fat reduction is achievable, GLP-1 therapy will not produce a flat stomach or eliminate all belly fat, particularly in those with substantial weight to lose
Reduced blood flow can cause pain, especially during physical activity
Some people pay up to $150 or more per month, but some plans cover the medication fully
1 Select confirmatory secondary endpoints included the proportion of participants achieving 10%, 15%, 20% and 25% weight loss, with semaglutide 7.2 mg vs placebo (and for 20% and 25%, semaglutide 7.2 mg vs semaglutide 2.4 mg)
When your pen contains less than 1 mg, the dose counter stops before 1 mg is shown